MiniMed Group Inc (NASDAQ:MMED) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Consensus "Moderate Buy": Thirteen brokerages cover MiniMed Group, with 11 issuing buy ratings and 2 holds, and the average 12‑month price target at about $22.45.
• MMED opened at $13.20 and sits near its 52‑week low ($12.80) versus a 52‑week high of $20.48, trading well below the analysts' average target.
• Recent initiations show mixed views: Mizuho and William Blair started coverage with "outperform" ratings (Mizuho TP $21), Deutsche Bank started with a "buy" ($20), Piper Sandler with "neutral" ($16), and Zacks upgraded to "hold."

MiniMed Group Inc (NASDAQ:MMED - Get Free Report) has received a consensus rating of "Moderate Buy" from the thirteen brokerages that are covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $22.4545.

Several analysts recently commented on the stock. Mizuho assumed coverage on shares of MiniMed Group in a report on Tuesday, March 31st. They set an "outperform" rating and a $21.00 price target for the company. Deutsche Bank Aktiengesellschaft began coverage on shares of MiniMed Group in a research note on Tuesday, March 31st. They issued a "buy" rating and a $20.00 target price for the company. Piper Sandler began coverage on shares of MiniMed Group in a research note on Tuesday, March 31st. They issued a "neutral" rating and a $16.00 target price for the company. Zacks Research upgraded shares of MiniMed Group to a "hold" rating in a research note on Thursday, April 9th. Finally, William Blair began coverage on shares of MiniMed Group in a research note on Tuesday, March 31st. They issued an "outperform" rating for the company.

MiniMed Group Stock Performance

MMED stock opened at $13.20 on Friday. MiniMed Group has a 52 week low of $12.80 and a 52 week high of $20.48.

MiniMed Group (NASDAQ:MMED - Get Free Report) last posted its quarterly earnings results on Friday, April 17th. The company reported $999.00 EPS for the quarter.

MiniMed Group Company Profile

We are a scaled global medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. Since our founding more than 40 years ago, we have pioneered groundbreaking innovation and served the needs of our customers across the globe in service of our mission to make every day a better day for people with diabetes. Today, we are the only player in the market that commercializes all parts of an integrated diabetes management system.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.